Table 3. Univariate analysis of survival in patients with GC.

Variable	Mean survival time month (±SE)	95% CI (Month)	P
Age (years)			0.132
<60	57.3(4.8)	47.9-66.6
≥60	48.9(3.4)	42.3-55.5
Gender			0.668
Male	52.5(3.3)	46.0-59.0
Female	50.5(5.1)	40.6-60.4
Tumour site			0.986
Gastric cardia	53.0(7.4)	38.5-67.4
Non-cardia	51.8(3.0)	45.9-57.7
Stage of disease			0.000
I–II	70.0(4.0)	62.2-77.8
III–IV	39.4(3.4)	32.8-46.1
Tumour status (p)			0.008
T1−T2	67.5(5.6)	56.5-78.4
T3−T4	48.5(3.0)	42.6-54.4
Node status			0.000
Negative	72.9(4.8)	63.6-82.3
Positive	44.8(3.1)	38.7-51.0
Distant metastasis			0.005
No	54.0(2.9)	48.2-59.7
Yes	30.2(6.4)	17.6-42.8
FGF9			0.000
High expression	28.1(3.5)	21.2-35.0
Low/unchanged	55.8(3.5)	48.9-62.7
Tumour size (cm)
≥10	28.4(5.0)	18.5-38.2	0.001
<10	54.8(3.1)	48.8-60.8